Angiocentric nasal T/natural killer cell lymphoma: A single centre study of prognostic factors in 108 patients

Clinical and Laboratory Haematology

Volumn 22, Issue 4, 2000, Pages 215-220

  Avilés, Agustin ^a,b   Diaz N R ^a   Neri, N ^a   Cleto, S ^a   Talavera, A ^a  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

^b NONE   (Mexico)

Author keywords

International prognostic index; Nasal cavity; Prognostic factors; Single centre; T NK cell lymphoma

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; NOSE CANCER; PRIORITY JOURNAL; T CELL LYMPHOMA;

ADULT; AGED; BETA 2-MICROGLOBULIN; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KILLER CELLS, NATURAL; L-LACTATE DEHYDROGENASE; LYMPHOMA, T-CELL; MALE; MEXICO; MIDDLE AGED; NOSE NEOPLASMS; PROGNOSIS; RISK FACTORS; SURVIVAL RATE;

EID: 0033783349     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.2000.00307.x     Document Type: Article

References (21)

1. Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma
2. New approach to classifying non-Hodgkin's lymphomas. Clinical fatures of the major histopathological subtypes
3. Angiocentric T-cell lymphoma of the nose, paranasal sinuses and hard palate
4. Combined therapy for angioimmunoproliferative lesions
5. The International Index is not useful in the classification of low grade lymphoma
6. Beta 2 microglobulin and lactate dehydrogenase levels are useful prognostic markers in early stage primary gastric lymphoma
7. Primary non-Hodgkin's lymphoma of the nose, and naso pharyne clinical features tumor immunopheno-type and treatment autocome in 113 patients
8. Regression models and life tables
9. Nasal lymphoma. A clinicopathological study with immunophenotypic and genotic analysis
10. The usefulness of immunophenotype and genotypic studies in the diagnosis and classification of hematopoietic and lymphoid neoplasms
11. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphoma
12. The International Prognostic Index for aggressive lymphoma is valid for all malignancy cases
13. Report of the workshop of nasal and related extranodal angiocentric T/natural killer cell lymphoma
14. CD 56+NK lymphomas clinicopathological features and prognosis
15. Treatment outcome and prognostic Factors for primary nasal lympoma
16. Lymphoma of nasal cavity and para nasal sinueses. Improved outcome and altered prognostic factors with combined therapy
17. Evaluation of the Revised European American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma
18. Application of the International Prognostic Index in the study of Chinese population with non-Hodgkn's lympona and high incidence of primary extranodal lymphoma
19. A multivariate analysis of the survival of patients with aggressive lymphoma
20. Primary lymphoma of the nasal cavity and paranasal sinuses
21. Predictive model for aggressive non-Hodgkin's lymphoma